Redhill Biopharma Ltd
Change company Symbol lookup
Select an option...
RDHL Redhill Biopharma Ltd
KRON Kronos Bio Inc
NVSAW New Vista Acquisition Corp *W EXP 02/01/2026
$R25IGTRI Russell 2500 Growth TR Index
QQQ Invesco QQQ Trust
PRDO Perdoceo Education Corp
DITHF DS Smith PLC
BIOL BIOLASE Inc
GOEV Canoo Inc
CHE Chemed Corp
Go

Health Care : Pharmaceuticals |
Based in Israel
Company profile

Redhill Biopharma Ltd is an Israel-basedis a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The Company promotes three gastrointestinal drugs in the US: Movantik, Talicia and Aemcolo. Key programs in it pipeline of late-stage clinical assets include: opaganib (Yeliva) and RHB-107 for multiple indications including COVID-19, RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease and RHB-104 for Crohn's disease.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$4.89
Day's Change
-0.07 (-1.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.99
Day's Low
4.84
Volume
(Light)
Volume:
267,342

10-day average volume:
1,335,042
267,342
  • Prev Close
    4.96
  • Today's Open
    4.95
  • Day's Range
    4.84-4.99
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    4:00p ET 10/15/21
  • Last (size)
    1
  • 52-Wk Range
    4.14 - 11.52
    LowHigh
  • (02/22/21 - 09/30/21)
    18.12%
  • 77.6%
  • Market Cap
    228.5M
  • Shares Outstanding
    46.7M
  • -2.30
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.7
  • 17.47
  • (% of float 09/30/21)
    3.88

Latest News

October 12, 2021
7:02 am ET
Accesswire
7:00 am ET
PR Newswire
October 06, 2021
7:02 am ET
Accesswire
7:00 am ET
PR Newswire
October 05, 2021
6:59 am ET
MarketWatch
October 04, 2021
9:31 am ET
PR Newswire
8:48 am ET
MarketWatch
8:16 am ET
Accesswire
8:00 am ET
PR Newswire
September 23, 2021
7:00 am ET
PR Newswire
September 14, 2021
8:15 am ET
PR Newswire
September 13, 2021
7:02 am ET
Accesswire
7:00 am ET
PR Newswire
September 07, 2021
7:02 am ET
Accesswire
August 27, 2021
9:31 am ET
PR Newswire
August 26, 2021
7:31 am ET
Accesswire
7:00 am ET
PR Newswire
6:30 am ET
Accesswire
6:00 am ET
PR Newswire
August 23, 2021
7:05 am ET
Accesswire
7:00 am ET
PR Newswire
August 19, 2021
7:00 am ET
PR Newswire
July 22, 2021
11:00 am ET
Accesswire
9:47 am ET
Accesswire
9:19 am ET
PR Newswire
July 20, 2021
8:03 am ET
Accesswire
7:00 am ET
PR Newswire
July 19, 2021
10:16 am ET
Accesswire
7:00 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.